日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD

血清干扰素-λ3作为抗MDA5阳性皮肌炎相关间质性肺病疾病控制的短期生物标志物

Kitahara, Yoshihiro; Fujisawa, Tomoyuki; Fukada, Atsuki; Koda, Keigo; Akamatsu, Taisuke; Ikeda, Masaki; Fujii, Masato; Niwa, Mitsuru; Kaida, Yusuke; Matsuda, Hiroyuki; Yokomura, Koshi; Koshimizu, Naoki; Toyoshima, Mikio; Imokawa, Shiro; Hashimoto, Dai; Yamashita, Keita; Iwaizumi, Moriya; Maekawa, Masato; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Inui, Naoki; Suda, Takafumi

Prognostic value of computed tomography assessment of normal lung volume in upper lobe in idiopathic pleuroparenchymal fibroelastosis

计算机断层扫描评估上叶正常肺容积对特发性胸膜肺实质纤维弹性病预后的价值

Suzuki, Yuzo; Kono, Masato; Hasegawa, Hirotsugu; Hashimoto, Dai; Yokomura, Koshi; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

Antifibrotic therapy in familial idiopathic pulmonary fibrosis: a comparative cohort study

家族性特发性肺纤维化抗纤维化治疗:一项比较队列研究

Morikawa, Keisuke; Suzuki, Yuzo; Kato, Shinpei; Kono, Masato; Hashimoto, Dai; Yokomura, Koshi; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Karayama, Masato; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort Studies

接受免疫检查点抑制剂治疗的晚期非小细胞肺癌患者停药后的生存情况:前瞻性队列研究的汇总分析

Inoue, Yusuke; Kitahara, Yoshihiro; Karayama, Masato; Asada, Kazuhiro; Nishimoto, Koji; Matsuura, Shun; Hashimoto, Dai; Fujii, Masato; Matsui, Takashi; Inami, Nao; Toyoshima, Mikio; Matsuda, Hiroyuki; Ikeda, Masaki; Niwa, Mitsuru; Kaida, Yusuke; Sato, Masaki; Ito, Yasuhiro; Yasui, Hideki; Suzuki, Yuzo; Hozumi, Hironao; Furuhashi, Kazuki; Enomoto, Noriyuki; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi

Predictive risk factors of treatment-refractory Mycobacterium avium complex lung disease: a single-center retrospective cohort study

难治性鸟分枝杆菌复合群肺病的预测风险因素:一项单中心回顾性队列研究

Saito, Takahiko; Aono, Yuya; Kono, Masato; Ishige, Masaki; Sugiura, Takuma; Higasa, Misato; Nihashi, Fumiya; Katsumata, Mineo; Miwa, Hideki; Miki, Yoshihiro; Hashimoto, Dai

Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials

奥氮平联合三联止吐疗法预防卡铂引起的恶心:两项临床试验的汇总分析

Kojima, Suguru; Inui, Naoki; Suzuki, Takahito; Tanaka, Kazuki; Karayama, Masato; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Nishimoto, Koji; Matsuura, Shun; Hashimoto, Dai; Matsui, Takashi; Asada, Kazuhiro; Suda, Takafumi

Idiopathic multicentric Castleman disease developing after a diagnosis of sarcoidosis: A case report and literature review

特发性多中心性卡斯尔曼病发生于结节病诊断之后:病例报告及文献综述

Muramatsu, Takumi; Kono, Masato; Ishige, Masaki; Saito, Takahiko; Higasa, Misato; Nihashi, Fumiya; Aono, Yuya; Katsumata, Mineo; Miwa, Hideki; Miki, Yoshihiro; Misaki, Taro; Otsuki, Yoshiro; Hashimoto, Dai; Enomoto, Noriyuki; Suda, Takafumi; Nakamura, Hidenori

Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial

奥氮平联合三联止吐疗法预防卡铂引起的恶心和呕吐:一项随机、双盲、安慰剂对照的III期试验

Inui, Naoki; Suzuki, Takahito; Tanaka, Kazuki; Karayama, Masato; Inoue, Yusuke; Mori, Kazutaka; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Matsuura, Shun; Nishimoto, Koji; Matsui, Takashi; Asada, Kazuhiro; Hashimoto, Dai; Fujii, Masato; Niwa, Mitsuru; Uehara, Masahiro; Matsuda, Hiroyuki; Koda, Keigo; Ikeda, Masaki; Inami, Nao; Tamiya, Yutaro; Kato, Masato; Nakano, Hideki; Mino, Yasuaki; Enomoto, Noriyuki; Suda, Takafumi

Risk factors for relapse of immune-related pneumonitis after 6-week oral prednisolone therapy: a follow-up analysis of a phase II study

口服泼尼松龙治疗6周后免疫相关性肺炎复发的危险因素:一项II期研究的随访分析

Karayama, Masato; Inui, Naoki; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Asada, Kazuhiro; Nishimoto, Koji; Fujii, Masato; Matsui, Takashi; Matsuura, Shun; Hashimoto, Dai; Toyoshima, Mikio; Ikeda, Masaki; Matsuda, Hiroyuki; Inami, Nao; Kaida, Yusuke; Funayama, Satoshi; Ichikawa, Shintaro; Goshima, Satoshi; Suda, Takafumi

A predictive model for acute exacerbation of idiopathic interstitial pneumonias

特发性间质性肺炎急性加重的预测模型

Karayama, Masato; Aoshima, Yoichiro; Suzuki, Takahito; Mori, Kazutaka; Yoshizawa, Nobuko; Ichikawa, Shintaro; Kato, Shinpei; Yokomura, Koshi; Kono, Masato; Hashimoto, Dai; Inoue, Yusuke; Yasui, Hideki; Hozumi, Hironao; Suzuki, Yuzo; Furuhashi, Kazuki; Fujisawa, Tomoyuki; Enomoto, Noriyuki; Goshima, Satoshi; Inui, Naoki; Suda, Takafumi